Is Zhong Yuan BioTechnology stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Zhong Yuan BioTechnology 10 years ago, but if you had invested on Friday 4th of June 2021 when the price was $0.510, you would have made a profit of $4.48 per share or 878.43%
We do not have enough data to give you this answer.
Zhong Yuan BioTechnology has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.21, the company's ability to pay off the debt is normal. Zhong Yuan BioTechnology has a very good net profit margin of 28.44% and should have very high tolerances against inflation.
We have calculated the inflation risk for Zhong Yuan BioTechnology to be low [0.45 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.